false 0000700841 0000700841 2024-11-07 2024-11-07
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):  November 7, 2024
 
RCM Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Nevada
(State or Other
Jurisdiction of
Incorporation)
1-10245
(Commission File
Number)
95-1480559
(I.R.S. Employer
Identification No.)
 
2500 McClellan Avenue, Suite 350
   
Pennsauken, NJ
 
08109-4613
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (856) 356-4500 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)).
 
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.05 per share
 
RCMT
 
The NASDAQ Stock Market LLC
 
 

 
 
Item 2.02.       Results of Operations and Financial Condition.
 
On November 7, 2024, the Registrant issued a press release regarding its financial results for the thirteen and thirty-nine weeks ended September 28, 2024.  A copy of the press release is furnished as Exhibit 99 to this report.
 
The information set forth under this “Item 2.02. Results of Operations and Financial Condition” (including the exhibit) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Registrant pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto.
 
Item 9.01.       Financial Statements and Exhibits.
 
(a) Financial Statements of Businesses Acquired.
 
None.
 
(b) Pro Forma Financial Information.
 
None.
 
(c) Shell Company Transactions.
 
None.
 
(d) Exhibits.
 
Exhibit Number
 
Press Release by the Registrant, dated November 7, 2024, furnished in accordance with Item 2.02 of this Current Report on Form 8-K.
104
Cover Page Interactive Data File (formatted as Inline XBRL).
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
RCM TECHNOLOGIES, INC.
 
 
 
By:
/s/ Kevin D. Miller
 
Kevin D. Miller
 
Chief Financial Officer, Treasurer and
Secretary
 
Dated: November 7, 2024
 

Exhibit 99

 image01.jpg

RCM Technologies, Inc.

Tel: 856.356.4500

Corporate Contacts:

2500 McClellan Avenue

info@rcmt.com

Bradley S. Vizi

Pennsauken, NJ 08109

www.rcmt.com

Executive Chairman

 

 

Kevin D. Miller

   

Chief Financial Officer

 

 

P R E S S   R E L E A S E

 

RCM TECHNOLOGIES, INC. ANNOUNCES

THIRD QUARTER RESULTS

 

Pennsauken, NJ – November 7, 2024 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and thirty-nine weeks ended September 28, 2024.

 

RCM Technologies reported revenue of $60.4 million for the thirteen weeks ended September 28, 2024 (the current quarter), an increase of 4.0% compared to $58.0 million for the thirteen weeks ended September 30, 2023 (the comparable prior quarter). Gross profit was $17.8 million for the current quarter, a 3.2% increase compared to $17.3 million for the comparable prior quarter.  The Company experienced GAAP net income of $2.7 million, or $0.35 per diluted share, for the current quarter compared to $3.8 million, or $0.46 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $5.6 million for the current quarter, a 9.5% increase compared to $5.1 million for the comparable prior quarter.  The Company experienced $0.44 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.50 for the comparable prior quarter.

 

RCM Technologies reported revenue of $201.5 million for the thirty-nine weeks ended September 28, 2024 (the current period), an increase of 4.8% compared to $192.2 million for the thirty-nine weeks ended September 30, 2023 (the comparable prior-year period). Gross profit was $58.2 million for the current period, a 5.7% increase compared to $55.1 million for the comparable prior-year period.  The Company experienced GAAP net income of $10.5 million, or $1.31 per diluted share, for the current period compared to $11.6 million, or $1.33 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA (non-GAAP) of $19.6 million for the current period, a 10.5% increase compared to $17.7 million for the comparable prior-year period.  The Company experienced $1.54 of adjusted net income per diluted share (non-GAAP) for the current period as compared to $1.41 for the comparable prior-year period.

 

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “Third-quarter growth was led by Healthcare and Engineering, as both businesses continue to ramp in their respective end markets.”

 

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “Growth remains consistent, while we anticipate enhanced cash conversion in coming quarters.”

 

 

 

 

Conference Call

On Friday, November 8, 2024, RCM Technologies will host a conference call to discuss these results. The call will begin at 1:00 p.m. Eastern Time. The dial-in number is (888) 272-8703.

 

About RCM

RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

 

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

 

Tables to Follow

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

 

 

Thirteen Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

Revenue

$60,365

 

$58,049

 

Cost of services

42,524

 

40,768

 

Gross profit

17,841

 

17,281

 

Selling, general and administrative

13,018

 

12,662

 

Depreciation and amortization of property and equipment

393

 

243

 

Amortization of acquired intangible assets

45

 

45

 

Operating income

4,385

 

4,331

 

Other expense, net

619

 

141

 

Income before income taxes

3,766

 

4,190

 

Income tax expense

1,020

 

434

 

Net income

$2,746

 

$3,756

 
         

Diluted net earnings per share data

$0.35

 

$0.46

 

Diluted weighted average shares outstanding

7,789,446

 

8,196,330

 

 

 

 

Thirty-Nine Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

Revenue

$201,468

 

$192,209

 

Cost of services

143,259

 

137,144

 

Gross profit

58,209

 

55,065

 

Selling, general and administrative

40,762

 

38,782

 

Depreciation and amortization of property and equipment

1,012

 

756

 

Amortization of acquired intangible assets

136

 

136

 

Costs associated with potential stock issuance

259

 

-

 

Gain on sale of assets

-

 

(395

)

Operating income

16,040

 

15,786

 

Other expense, net

1,619

 

965

 

Income before income taxes

14,421

 

14,821

 

Income tax expense

3,961

 

3,245

 

Net income

$10,460

 

$11,576

 
         

Diluted net earnings per share data

$1.31

 

$1.33

 

Diluted weighted average shares outstanding

7,990,238

 

8,730,998

 

 

 

 

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands)

 

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA,” “Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance.  In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

The following unaudited table presents the Company’s GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen and thirty-nine weeks ended September 28, 2024 and September 30, 2023.   

 

 

Thirteen Weeks Ended

 

Thirty-Nine Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

September 28,

2024

 

September 30,

2023

 
 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 
                 

GAAP operating income

$4,385

 

$4,331

 

$16,040

 

$15,786

 

Adjustments

               

Gain on sale of assets

-

 

-

 

-

 

(395

)

Costs associated with potential stock issuance

-

 

-

 

259

 

-

 

Equity compensation

767

 

484

 

2,154

 

1,451

 

Adjusted operating income (non-GAAP)

$5,152

 

$4,815

 

$18,453

 

$16,842

 
                 

GAAP net income

$2,746

 

$3,756

 

$10,460

 

$11,576

 

Income tax expense

1,020

 

434

 

3,961

 

3,245

 

Interest expense, net

492

 

185

 

1,551

 

970

 

Depreciation of property and equipment

393

 

243

 

1,012

 

756

 

Amortization of acquired intangible assets

45

 

45

 

136

 

136

 

EBITDA (non-GAAP)

$4,696

 

$4,663

 

$17,120

 

$16,683

 
                 

Adjustments

               

Gain on sale of assets

-

 

-

 

-

 

(395

)

Costs associated with potential stock issuance

-

 

-

 

259

 

-

 

Loss (gain) on foreign currency transactions

127

 

(44

)

68

 

(5

)

Equity compensation

767

 

484

 

2,154

 

1,451

 

Adjusted EBITDA (non-GAAP)

$5,590

 

$5,103

 

$19,601

 

$17,734

 

 

 

 

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis (Continued)

(Unaudited)

(In Thousands)

 

 

 

Thirteen Weeks Ended

 

Thirty-Nine Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

September 28,

2024

 

September 30,

2023

 
 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 
                 

GAAP net income

$2,746

 

$3,756

 

$10,460

 

$11,576

 

Adjustments

               

Gain on sale of assets

-

 

-

 

-

 

(395

)

Costs associated with potential stock issuance

-

 

-

 

259

 

-

 

Loss (gain) on foreign currency transactions

127

 

(44

)

68

 

(5

)

Equity compensation

767

 

484

 

2,154

 

1,451

 

Tax impact from normalized rate

(190

)

(138

)

(674

)

(295

)

Adjusted net income (non-GAAP)

$3,450

 

$4,058

 

$12,267

 

$12,332

 
                 

GAAP diluted net earnings per share

$0.35

 

$0.46

 

$1.31

 

$1.33

 

Adjustments

               

Gain on sale of assets

           

($0.04

)

Costs associated with potential stock issuance

-

 

-

 

$0.03

 

-

 

Loss (gain) on foreign currency transactions

$0.01

 

-

 

$0.01

 

-

 

Equity compensation

$0.10

 

$0.06

 

$0.27

 

$0.16

 

Tax impact from normalized rate

($0.02

)

($0.02

)

($0.08

)

($0.04

)

Adjusted diluted net earnings per share (non-GAAP)

$0.44

 

$0.50

 

$1.54

 

$1.41

 

 

 

 

RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

 

 

 

Thirteen Weeks Ended September 28, 2024

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences

and IT

 

Consolidated

 
                 

Revenue

$26,554

 

$24,167

 

$9,644

 

$60,365

 

Cost of services

18,271

 

18,273

 

5,980

 

42,524

 

Gross profit

8,283

 

5,894

 

3,664

 

17,841

 

Gross profit margin

31.2

%

24.4

%

38.0

%

29.6

%

 

 

 

 

Thirteen Weeks Ended September 30, 2023

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences

and IT

 

Consolidated

 
                 

Revenue

$24,895

 

$22,452

 

$10,702

 

$58,049

 

Cost of services

17,438

 

16,846

 

6,484

 

40,768

 

Gross profit

$7,457

 

$5,606

 

$4,218

 

$17,281

 

Gross profit margin

30.0

%

25.0

%

39.4

%

29.8

%

 

 

 

 

Thirty-Nine Weeks Ended September 28, 2024

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences

and IT

 

Consolidated

 
                 

Revenue

$101,668

 

$70,180

 

$29,620

 

$201,468

 

Cost of services

71,672

 

52,818

 

18,769

 

143,259

 

Gross profit

29,996

 

17,362

 

10,851

 

58,209

 

Gross profit margin

29.5

%

24.7

%

36.6

%

28.9

%

 

 

 

 

Thirty-Nine Weeks Ended September 30, 2023

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences

and IT

 

Consolidated

 
                 

Revenue

$99,553

 

$61,956

 

$30,700

 

$192,209

 

Cost of services

70,623

 

47,482

 

19,039

 

137,144

 

Gross profit

$28,930

 

$14,474

 

$11,661

 

$55,065

 

Gross profit margin

29.1

%

23.4

%

38.0

%

28.6

%

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In Thousands, Except Share Amounts)

 

 

September 28,

 

December 30,

 
 

2024

 

2023

 
 

(Unaudited)

     

Current assets:

       
 

Cash and cash equivalents

$3,156

 

$6,284

 
 

Accounts receivable, net of provision for credit losses of $1,600

 at September 28, 2024 and December 30, 2023

75,913

 

70,690

 
 

Transit accounts receivable

6,315

 

8,891

 
 

Prepaid expenses and other current assets

5,112

 

4,637

 
   

Total current assets

90,496

 

90,502

 
             

Property and equipment, net

6,793

 

4,005

 
         

Deposits

215

 

313

 

Deferred income taxes, foreign

55

 

55

 

Goodwill

22,147

 

22,147

 

Operating right of use asset

5,292

 

2,779

 

Intangible assets, net

547

 

683

 
   

Total other assets

28,256

 

25,977

 
             
   

Total assets

$125,545

 

$120,484

 

 

Current liabilities:

       
 

Accounts payable and accrued expenses

$11,525

 

$12,454

 
 

Transit accounts payable

28,215

 

31,102

 
 

Accrued payroll and related costs

11,634

 

11,203

 
 

Finance lease payable

689

 

233

 
 

Income taxes payable

220

 

330

 
 

Operating right of use liability

1,019

 

693

 
 

Contingent consideration from acquisitions

300

 

300

 
 

Deferred revenue

2,042

 

1,881

 
   

Total current liabilities

55,644

 

58,196

 
         

Deferred income taxes, net, foreign

185

 

187

 

Deferred income taxes, net, domestic

1,719

 

1,568

 

Finance lease payable, net of current position

1,290

 

-

 

Contingent consideration from acquisitions, net of current position

1,671

 

1,671

 

Operating right of use liability, net of current position

4,519

 

2,268

 

Borrowings under line of credit

30,477

 

30,804

 
 

Total liabilities

95,505

 

94,694

 
         

Contingencies (note 15)

-

 

-

 
         

Stockholders’ equity:

       
 

Preferred stock, $1.00 par value; 5,000,000 shares authorized;

       
   

no shares issued or outstanding

-

 

-

 
 

Common stock, $0.05 par value; 40,000,000 shares authorized;

       
   

17,833,287 shares issued and 7,597,028 shares outstanding at

September 28, 2024 and 17,673,427 shares issued and 7,844,821 shares

outstanding at December 30, 2023

890

 

882

 
 

Additional paid-in capital

118,136

 

116,579

 
 

Accumulated other comprehensive loss

(2,787

)

(2,813

)

 

Accumulated deficit

(8,805

)

(19,265

)

 

Treasury stock, 10,236,259 shares at September 28, 2024 and

       
   

9,828,606 shares at December 30, 2023, at cost

(77,394

)

(69,593

)

   

Total stockholders’ equity

30,040

 

25,790

 
             
   

Total liabilities and stockholders’ equity

$125,545

 

$120,484

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

 

 

Thirteen Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

Net income

$2,746

 

$3,756

 

Adjustments to reconcile net income to cash

 used in operating activities

1,508

 

1,049

 

Changes in operating assets and liabilities:

       
 

Accounts receivable

(9,033)

 

4,143

 
 

Prepaid expenses and other current assets

321

 

(987

)

 

Net of transit accounts receivable and payable

435

 

1,556

 
 

Accounts payable and accrued expenses

(1,445

)

(785

)

 

Accrued payroll and related costs

1,919

 

2,790

 
 

Right of use liabilities

(228

)

(333

)

 

Income taxes payable

81

 

15

 
 

Deferred revenue

(636

)

(169

)

 

Deposits

(12

)

2

 

Total adjustments

(7,090

)

7,281

 

Net cash (used in) provided by operating activities

($4,344

)

$11,037

 
         

Net cash (used in) provided by investing activities

(522

)

79

 

Net cash provided by (used in) financing activities

4,375

 

(11,343

)

Effect of exchange rate changes on cash and cash equivalents

167

 

(392

)

Decrease in cash and cash equivalents

($324

)

($619

)

         

Common stock repurchase

($2,410

)

($3,389

)

 

 

 

Thirty-Nine Weeks Ended

 
 

September 28,

2024

 

September 30,

2023

 

Net income

$10,460

 

$11,576

 

Adjustments to reconcile net income to cash

 used in operating activities

4,200

 

2,795

 

Changes in operating assets and liabilities:

       
 

Accounts receivable

(5,207

)

(6,696

)

 

Prepaid expenses and other current assets

(475

)

(675

)

 

Net of transit accounts receivable and payable

(311

)

22,384

 
 

Accounts payable and accrued expenses

(760

)

(1,798

)

 

Accrued payroll and related costs

433

 

1,596

 
 

Right of use liabilities

(686

)

(1,016

)

 

Income taxes payable

(106

)

162

 
 

Deferred revenue

161

 

(784

)

 

Deposits

98

 

4

 

Total adjustments

(2,653

)

15,972

 

Net cash provided by operating activities

7,807

 

27,548

 
         

Net cash used in investing activities

(1,589

)

(480

)

Net cash used in financing activities

(9,135

)

(26,558

)

Effect of exchange rate changes on cash and cash equivalents

(211

)

(195

)

(Decrease) increase in cash and cash equivalents

($3,128

)

$315

 
         

Common stock repurchase

($7,801

)

($24,449

)

 

 
v3.24.3
Document And Entity Information
Nov. 07, 2024
Document Information [Line Items]  
Entity, Registrant Name RCM Technologies, Inc.
Document, Type 8-K
Document, Period End Date Nov. 07, 2024
Entity, Incorporation, State or Country Code NV
Entity, File Number 1-10245
Entity, Tax Identification Number 95-1480559
Entity, Address, Address Line One 2500 McClellan Avenue, Suite 350
Entity, Address, City or Town Pennsauken
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 08109-4613
City Area Code 856
Local Phone Number 356-4500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Title of 12(b) Security Common Stock
Trading Symbol RCMT
Security Exchange Name NASDAQ
Amendment Flag false
Entity, Central Index Key 0000700841

RCM Technologies (NASDAQ:RCMT)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 RCM Technologies 차트를 더 보려면 여기를 클릭.
RCM Technologies (NASDAQ:RCMT)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 RCM Technologies 차트를 더 보려면 여기를 클릭.